Clinical Trial Update: Phase II Trial of Low-Dose Whole Brain Radiotherapy With Concurrent Temozolomide and Adjuvant Temozolomide in Patients With Newly-Diagnosed Glioblastoma Multiforme [Phase 2]

View source ↗

Summary

Phase II trial investigating low-dose whole brain radiotherapy with concurrent and adjuvant temozolomide in newly diagnosed glioblastoma multiforme; study statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Gliosarcoma

Drugs mentioned

• Temozolomide (Temozolomide)

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Histologically Proven Diagnosis of Glioblastoma or Gliosarcoma (WHO Grade IV) | Phase 2 | Status: TERMINATED | Results posted: 2022-12-29